The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies?

By afschroeder • February 13, 2026

Barrett LG, Gangi A, Hendifar A, Osipov A, Atkins K, Zaghiyan K, Nasseri Y, Murrell Z, Waters K, Mehta P, Zell JA, Hitchins MP, Gong J. The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies? Transl Gastroenterol Hepatol. 2026 Jan 23;11:2. doi: 10.21037/tgh-25-75. PMID: 41675310; PMCID: PMC12887280.

Tags: adjuvant chemotherapy (ACT), Cedars Sinai DoM, circulating tumor DNA (ctDNA), Colon cancer, Hematology/Oncology, minimal residual disease (MRD), Publications

Disparities in Health Care Seeking and Physician Diagnosis of Irritable Bowel Syndrome: Results From a United States Survey

Almario CV, Liu J, Higgins C, Yerneni N, Boules M, Chey WD, Chang L. Disparities in Health Care Seeking and Physician Diagnosis of Irritable Bowel[...]

Longitudinal Study on the Influence of Physical Activity in Managing Fatigue in Patients With Colorectal Cancer

Liu L, Kazemian E, Loroña NC, Shirazipour C, Gong J, Crowder SL, Nguyen N, Damerell V, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata[...]

Artificial intelligence-derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study

Ramirez G, Dharmavaram NL, Shanbhag A, Miller RJH, Kavanagh PB, Yi J, Lemley M, Builoff V, Marcinkiewicz A, Dey D, Hainer J, Wopperer S, Knight[...]